Acute Liver Failure With Liver Enzymes >5,000 in Sickle Cell Disease

Author:

Wadhavkar Neha1ORCID,Nsubuga John Paul2,Ibrahim Nouran3,Kumar Prasanna4,Hsu Andrew5,Simmons Shannon2

Affiliation:

1. Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI

2. Division of Gastroenterology, The Warren Alpert Medical School of Brown University, Providence, RI

3. The Warren Alpert Medical School of Brown University, Providence, RI

4. Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, Providence, RI

5. Division of Hematology Oncology, The Warren Alpert Medical School of Brown University, Providence, RI

Abstract

ABSTRACT Sickle cell disease is a hemoglobinopathy often complicated by painful vaso-occlusive episodes, acute chest syndrome, stroke, and myocardial infarction. Sickle cell intrahepatic cholestasis (SCIC) is a rare and potentially fatal complication of sickle cell disease. SCIC is thought to involve progressive hepatic injury due to sickling within sinusoids. We present the case of a young patient with SCIC and acute liver failure, requiring prompt treatment with exchange transfusion. Our case describes features that should raise suspicion for hepatic failure in SCIC and highlights exchange transfusion as a successful management approach in similar patients with an otherwise high risk of mortality.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference13 articles.

1. Management of sickle cell intrahepatic cholestasis: An argument in favor of automated exchange transfusion;Adkins;Clin Hematol Int.,2019

2. Intrahepatic cholestasis in a sickle cell patient unresponsive to exchange blood transfusion;Likhtshteyn;Am J Med Case Rep.,2020

3. Intrahepatic cholestasis in sickle cell disease: A case report;Brunetta;Anemia.,2010

4. Sickle cell intrahepatic cholestasis: Extremely rare but fatal complication of sickle cell disease;Khan;Cureus.,2022

5. Sickle cell hepatopathy: Clinical presentation, treatment, and outcome in pediatric and adult patients;Ahn;Pediatr Blood Cancer.,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3